Mutated TP53 and other tumor suppressor genes cannot be re-activated after chemoradiation to initiate the apoptosis of cancer cells, which might be associated with a worse prognosis and decreased sensitivity to chemoradiation therapy of HPV-negative OSCC in contrast to the HPV‐positive ones31,32. Here, TP53 is linked to cancer.